title: Obsessive-compulsive disorder in children.
abstract: Childhood OCD is a chronic and commonly disabling disorder with a lifetime prevalence of 2% to 3%. Traditionally OCD was a neglected diagnosis, but renewed research interest over the past decade has led to significant advances in the understanding of the disorder in young people. OCD is relatively consistent across the age span in terms of prevalence, phenomenology, etiology, and response to treatment. Comorbidity, especially depression and other anxiety disorders, is common in children with OCD and may exert a negative influence on treatment response and long-term outcome. Nevertheless, CBT and SSRI therapy have been shown to be effective and well-tolerated therapies for children with OCD.
authors.affiliation: Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles School of Medicine, USA. jcp@ucla.edu
authors.forename: J
authors.initials: J
authors.lastname: Piacentini
authors.forename: R L
authors.initials: RL
authors.lastname: Bergman
mesh_terms: D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000150:complications; D002648:Child; D015928:Cognitive Behavioral Therapy; D015897:Comorbidity; D003863:Depression / Q000453:epidemiology; D003937:Diagnosis, Differential; D005196:Family Therapy; D020022:Genetic Predisposition to Disease; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D015995:Prevalence; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013981:Tic Disorders / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
chemical_list: D014151:Anti-Anxiety Agents; D017367:Selective Serotonin Reuptake Inhibitors